MYLAN 2036 MYLAN 2036 (Topiramate (Sprinkle) 25 mg)
Pill with imprint MYLAN 2036 MYLAN 2036 is Pink, Capsule-shape and has been identified as Topiramate (Sprinkle) 25 mg. It is supplied by Mylan Pharmaceuticals Inc..
Topiramate is used in the treatment of epilepsy; seizure prevention; lennox-gastaut syndrome; migraine prevention; seizures and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Topiramate 25 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for MYLAN 2036 MYLAN 2036
Topiramate (Sprinkle)
- Imprint
- MYLAN 2036 MYLAN 2036
- Strength
- 25 mg
- Color
- Pink
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Carbonic anhydrase inhibitor anticonvulsants
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC)
- 00378-2036
More about topiramate
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 1081 Reviews
- Drug class: carbonic anhydrase inhibitor anticonvulsants
- FDA Alerts (3)
Consumer resources
- Topiramate
- Topiramate Extended-Release Sprinkle Capsules
- Topiramate Tablets
- Topiramate Extended-Release Capsules
- Topiramate Sprinkle Capsules
- Topiramate (Advanced Reading)
Other brands: Topamax, Trokendi XR, Qudexy XR, Topamax Sprinkle, Topiragen
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
